The Research Council of Norway’s Programme for Global Health and Vaccination Research (GLOBVAC) plays a key role in Norwegian efforts to improve the health of women and children and to fight infectious disease around the world.
An area in rapid development
There has been rapid growth in this research field in the past few years. The programme recently allocated NOK 146 million to 18 projects in the following areas: vaccine and vaccination research, health systems and health-policy research, innovation in technology and methods and implementation research.
Several of these projects will be headed by new, young researchers who received special “Young scientist grants” in this round of allocations.
Click here for the complete overview of projects receiving funding.
Research to aid the poorest of the poor
The primary focus of the GLOBVAC programme is research on vaccination, health systems and implementation and innovation. The programme is currently in its second programme period (2012-2020) during which time NOK 600 million will be distributed to research within these core areas.
“First and foremost, we will be supporting research to promote better health for the poorest segments of the population in low- and middle-income countries,” says Professor Peter Smith of the London School of Hygiene and Tropical Medicine and Chair of the GLOBVAC programme board.
Implementation research has received too little attention up to now, according to Dr Smith. The GLOBVAC programme will see this rectified during its current programme period.